Introduction. APCandTP53are tumor suppressor genes known to be altered frequently in human esophageal adenocarcinoma (EAC), which arises as a complication of reflux disease. To determine the functional role of these genes in the development of EAC, we have created reflux in mice gene-targeted for eitherTrp53orApc.Methods.Wild-type (WT), p53-knockout (Trp53−/−), orApc-mutated (ApcMin/+) mice were generated in our breeding colony. Total gastrectomy with esophagojejunostomy was performed at 6 weeks of age, creating jejunoesophageal reflux. Unoperated control mice were maintained under identical conditions. Mice were sacrificed at 30 weeks of age. Histology of the esophagus and jejunal anastamosis or gastroesophageal junction was reviewed by a single pathologist blinded to the genotype of the animal.Results.The esophagus was normal in all of the unoperated mice (6ApcMin/+, 6 WT, and 6Trp53−/−). All operated mice (6ApcMin/+, 12 WT, and 4Trp53−/−) had esophagitis, with squamous hyperplasia and early focal ulceration. Barrett's metaplasia was identified in 33% of the operatedApcMin/+(2/6) and 25% of theTrp53−/−(1/4) mice, but not in the WT mice. Of 4 operatedTrp53−/−mice, all developed severe dysplasia of the squamous epithelium and 2 (50%) had EAC on histology, although no gross tumors were seen. No severe dysplasia or carcinoma was identified in any of theApcMin/+or WT mice.Conclusions.Loss of eitherTrp53orApcleads to the development of columnar metaplasia, whereas loss ofTrp53,but notApc,leads to development of cancer in mice with jejunoesophageal reflux.